SCHEMBL530340

SCHEMBL530340

N#COc1ccccc1[N+](=O)[O-]

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.58
TDP1 Q9NUW8 2/20 0.58
NPC1 O15118 2/20 0.56
RAB9A P51151 2/20 0.56
RECQL P46063 1/20 0.56
HPGD P15428 2/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
KMT2A Q03164 4/20 0.45
MEN1 O00255 3/20 0.45
HTT P42858 2/20 0.45
LMNA P02545 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
KDM4E B2RXH2 1/20 0.44
HSD17B10 Q99714 1/20 0.44
CTDSP1 Q9GZU7 1/20 0.42
ESR2 Q92731 1/20 0.42
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30255416 1.00 ALDH1A1 (0.58) ALDH1A1TDP1NPC1RAB9ARECQL
SCHEMBL95864 0.82 ALDH1A1 (0.60) ALDH1A1TDP1NPC1RAB9ARECQL
SCHEMBL22485754 0.82 TDP1 (0.58) ALDH1A1TDP1NPC1RAB9ARECQL
SCHEMBL28712296 0.79 ALDH1A1 (0.40) ALDH1A1TDP1NPC1RAB9ARECQL
SCHEMBL10629488 0.78 TDP1 (0.42) ALDH1A1TDP1NPC1RAB9ARECQL
SCHEMBL11802004 0.78 ALDH1A1 (0.59) ALDH1A1TDP1NPC1RAB9ARECQL
SCHEMBL27493067 0.78 ALDH1A1 (0.64) ALDH1A1TDP1NPC1RAB9ARECQL
SCHEMBL39472 0.77 HPGD (0.78) ALDH1A1TDP1NPC1RAB9ARECQL
SCHEMBL22551751 0.77 RAB9A (0.66) ALDH1A1TDP1NPC1RAB9ARECQL
SCHEMBL28056476 0.75 L3MBTL1 (0.81) ALDH1A1TDP1NPC1RAB9ARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 214 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3438146-B1 CYANIC ACID ESTER COMPOUND AND METHOD FOR PRODUCING SAME, RESIN COMPOSITION, CURED ARTICLE, PREPREG, SEALING MATERIAL, FIBER-REINFORCED COMPOSITE MATERIAL, ADHESIVE AGENT, METAL FOIL-CLAD LAMINATE PLATE, RESIN SHEET, AND PRINTED WIRING BOARD MITSUBISHI GAS CHEMICAL CO (JP) 2026-04-08 EP disclosed
US-12486371-B2 Thermally curable resin composition, cured object, resin sheet, prepreg, metal-clad laminate, multilayered printed wiring board, sealing material, fiber-reinforced composite material, adhesive, and semiconductor device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2025-12-02 US disclosed
EP-3805293-B1 RESIN COMPOSITION, PREPREG, METAL FOIL-CLAD LAMINATE, RESIN SHEET, AND PRINTED WIRING BOARD MITSUBISHI GAS CHEMICAL CO (JP) 2025-09-17 EP disclosed
US-12312323-B2 Compound, method for producing same, resin composition, resin sheet, multilayer printed wiring board, and semiconductor device MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2025-05-27 US disclosed
CN-115003716-B Resin composition, resin sheet, prepreg, and printed wiring board 三菱瓦斯化学株式会社 2025-04-11 CN disclosed
US-20250109222-A1 CYCLIC ORGANOSILOXANE CONTAINING IMIDE BOND AND POLYMERIZABLE UNSATURATED BOND, AND CURABLE RESIN COMPOSITION COMPRISING SAID CYCLIC ORGANOSILOXANE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-04-03 US disclosed
WO-2025051267-A1 LPAR1 ANTAGONIST AND USE THEREOF 西藏海思科制药有限公司 2025-03-13 WO disclosed
EP-4438655-A1 CYCLIC ORGANOSILOXANE CONTAINING IMIDE BOND AND POLYMERIZABLE UNSATURATED BOND, AND CURABLE RESIN COMPOSITION COMPRISING SAID CYCLIC ORGANOSILOXANE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2024-10-02 EP disclosed
US-12091542-B2 Resin composition, prepreg, metal foil-clad laminate, resin sheet, and printed wiring board MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2024-09-17 US disclosed
WO-2024162321-A1 RESIN COMPOSITION, RESIN SHEET, MULTILAYER PRINTED WIRING BOARD, AND SEMICONDUCTOR DEVICE 三菱瓦斯化学株式会社 2024-08-08 WO disclosed
CN-1882612-A Hypo-and hyper-acetylated meningococcal capsular saccharides CHIRON SRL (IT) 2006-12-20 CN disclosed
EP-1664319-A2 PROCESS FOR PRODUCING A CAPSULAR POLYSACCHARIDE FOR USE IN CONJUGATE VACCINES Nederlands Vaccininstituut (NL) 2006-06-07 EP disclosed
WO-2005024038-A2 PROCESS FOR PRODUCING A CAPSULAR POLYSACCHARIDE FOR USE IN CONJUGATE VACCINES NEDERLANDS VACCININSTITUUT (NL) 2005-03-17 WO disclosed
WO-2004005270-A1 AZA-PEPTIDE EPOXIDES GEORGIA TECH RESEARCH CORPORATION (US) 2004-01-15 WO disclosed
US-5623006-A HAVING GAP FILLED WITH CURED POLYCYANURATE BINDER INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1997-04-22 US disclosed
US-5536765-A CYANATE TRIMERIZATION INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1996-07-16 US disclosed
US-5468790-A Useful in forming interconnection structures for integrated semiconductor devices INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1995-11-21 US disclosed
EP-0604823-A1 Triazine polymer and use thereof International Business Machines Corporation (US) 1994-07-06 EP disclosed
EP-0131801-A1 Process for the preparation of substituted ethylene ureas, and N-vinyl ethylene ureas BAYER AG (DE) 1985-01-23 EP disclosed
US-3994949-A REACTION OF PHENOLATE WITH CYANOGEN HALIDE, TERT-AMINE CATALYST BAYER AKTIENGESELLSCHAFT (DT) 1976-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250109222-A1 CYCLIC ORGANOSILOXANE CONTAINING IMIDE BOND AND POLYMERIZABLE UNSATURATED BOND, AND CURABLE RESIN COMPOSITION COMPRISING SAID CYCLIC ORGANOSILOXANE ZYX, MUS81, H1-0 ALDH1A1 3113/4885TDP1 3461/4885NPC1 4719/4885
US-12312323-B2 Compound, method for producing same, resin composition, resin sheet, multilayer printed wiring board, and semiconductor device ASH2L, RER1, SEM1 ALDH1A1 659/4885TDP1 1551/4885NPC1 4434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.